BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9016476)

  • 21. Inhaled prostacyclin and high-frequency oscillatory ventilation in a premature infant with respiratory syncytial virus-associated respiratory failure.
    Gupta M; Guertin S; Martin S; Omar S
    Pediatrics; 2012 Aug; 130(2):e442-5. PubMed ID: 22753555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of infants with severe respiratory failure and persistence of the fetal circulation, without hyperventilation.
    Wung JT; James LS; Kilchevsky E; James E
    Pediatrics; 1985 Oct; 76(4):488-94. PubMed ID: 4047792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surfactant treatment of an infant with acute idiopathic pulmonary hemorrhage.
    Neumayr TM; Watson AM; Wylam ME; Ouellette Y
    Pediatr Crit Care Med; 2008 Jan; 9(1):e4-6. PubMed ID: 18477904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity.
    Fodha I; Vabret A; Ghedira L; Seboui H; Chouchane S; Dewar J; Gueddiche N; Trabelsi A; Boujaafar N; Freymuth F
    J Med Virol; 2007 Dec; 79(12):1951-8. PubMed ID: 17935185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants.
    Löfgren J; Rämet M; Renko M; Marttila R; Hallman M
    J Infect Dis; 2002 Feb; 185(3):283-9. PubMed ID: 11807709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Non-invasive ventilation in infants with severe infection presumably due to respiratory syncytial virus: feasibility and failure criteria].
    Campion A; Huvenne H; Leteurtre S; Noizet O; Binoche A; Diependaele JF; Cremer R; Fourier C; Sadik A; Leclerc F
    Arch Pediatr; 2006 Nov; 13(11):1404-9. PubMed ID: 16978849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis.
    Tibby SM; Hatherill M; Wright SM; Wilson P; Postle AD; Murdoch IA
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1251-6. PubMed ID: 11029326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pertussis is common in nonvaccinated infants hospitalized for respiratory syncytial virus infection.
    Korppi M; Hiltunen J
    Pediatr Infect Dis J; 2007 Apr; 26(4):316-8. PubMed ID: 17414394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group.
    Moler FW; Steinhart CM; Ohmit SE; Stidham GL
    J Pediatr; 1996 Mar; 128(3):422-8. PubMed ID: 8774517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe bronchiolitis and respiratory syncytial virus among young children in Hawaii.
    Yorita KL; Holman RC; Steiner CA; Effler PV; Miyamura J; Forbes S; Anderson LJ; Balaraman V
    Pediatr Infect Dis J; 2007 Dec; 26(12):1081-8. PubMed ID: 18043442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience.
    DeVincenzo JP; Hirsch RL; Fuentes RJ; Top FH
    Bone Marrow Transplant; 2000 Jan; 25(2):161-5. PubMed ID: 10673674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological mechanisms of severe respiratory syncytial virus bronchiolitis.
    Bont L; Kimpen JL
    Intensive Care Med; 2002 May; 28(5):616-21. PubMed ID: 12029411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiologic risk factors for respiratory viral infections and immunoprophylaxis for respiratory syncytial virus in young children with congenital heart disease.
    Cabalka AK
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S41-5. PubMed ID: 14730269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases.
    Welliver TP; Reed JL; Welliver RC
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S92-6. PubMed ID: 18820587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current news about epidemiology of syncytial respiratory virus infection].
    Palumbo E
    Recenti Prog Med; 2008 May; 99(5):237-9. PubMed ID: 18581965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular epidemiology of respiratory syncytial virus infection in infants].
    Sun L; Jiao L; Wang C
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Dec; 13(4):380-2. PubMed ID: 12759984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative effects of palivizumab and donor-derived T cells on chronic respiratory syncytial virus infection, lung disease, and fusion glycoprotein amino acid sequences in a patient before and after bone marrow transplantation.
    El Saleeby CM; Suzich J; Conley ME; DeVincenzo JP
    Clin Infect Dis; 2004 Jul; 39(2):e17-20. PubMed ID: 15307047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention and treatment of respiratory syncytial virus infections (for advances in pediatric infectious diseases).
    DeVincenzo J
    Adv Pediatr Infect Dis; 1997; 13():1-47. PubMed ID: 9544306
    [No Abstract]   [Full Text] [Related]  

  • 39. [Exogenous surfactant. A rescue treatment in a neonate with varicella complicated with pneumonia].
    Clington A; Pereira-da-Silva L; Serelha M
    An Esp Pediatr; 2002 Nov; 57(5):493-4. PubMed ID: 12467559
    [No Abstract]   [Full Text] [Related]  

  • 40. Surfactant protein levels in severe respiratory syncytial virus infection.
    Kerr MH; Paton JY
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1115-8. PubMed ID: 10194154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.